共 50 条
[24]
Discovery and development of a new commercial route for a key regulatory starting material in the synthesis of PI3k β-sparing inhibitor GDC-0032 (Taselisib)
[J].
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,
2014, 248